Articles dans des revues avec comité de lecture (78)

  1. 51. Rothenberg, M. E., Klion, A. D., Roufosse, F., Kahn, J., Weller, P. F., & Simon, H.-U. (2008). Treatment of patients with the hypereosinophilic syndrome with mepolizumab. The New England journal of medicine, 358(12), 1215-1228. doi:10.1056/NEJMoa070812
  2. 52. Cogan, E., & Roufosse, F. (2007). Éosinophilie, syndrome de Churg-Strauss et syndrome hyperéosinophilique. La Revue de Medecine Interne, 28(SUPPL. 4), S256-S258. doi:10.1016/j.revmed.2007.09.001
  3. 53. Huez, S., Roufosse, F., Vachiery, J.-L., Pavelescu, A., Derumeaux, G., Wautrecht, J.-C., Cogan, E., & Naeije, R. (2007). Isolated right ventricular dysfunction in systemic sclerosis: latent pulmonary hypertension? The European respiratory journal, 30(5), 928-936. doi:10.1183/09031936.00025607
  4. 54. Roufosse, F., & Meric De Bellefon, L. (2007). Systemic sclerosis (Scleroderma). Acta clinica Belgica (Ed. multilingue), 62(5), 323-329.
  5. 55. Roufosse, F., Cogan, E., & Goldman, M. (2007). Lymphocytic variant hypereosinophilic syndromes. Immunology and allergy clinics of North America, 27(3), 389-413. doi:10.1016/j.iac.2007.07.002
  6. 56. Vanthuyne, M., Blockmans, D., Westhovens, R., Roufosse, F., Cogan, E., Coche, E., Nzeusseu Toukap, A., Depresseux, G., & Houssiau, F. A. (2007). A pilot study of mycophenolate mofetil combined to intravenous methylprednisolone pulses and oral low-dose glucocorticoids in severe early systemic sclerosis. Clinical and Experimental Rheumatology, 25(2), 287-292.
  7. 57. Roufosse, F., Goldman, M., & Cogan, E. (2007). Hypereosinophilic syndromes. Orphanet journal of rare diseases, 2, 37. doi:10.1186/1750-1172-2-37
  8. 58. Roufosse, F., Goldman, M., & Cogan, E. (2006). Hypereosinophilic syndrome: lymphoproliferative and myeloproliferative variants. Seminars in respiratory and critical care medicine, 27(2), 158-170. doi:10.1055/s-2006-939519
  9. 59. Vandergheynst, F., Ocmant, A., Sordet, C., Humbel, R., Goetz, J., Roufosse, F., Cogan, E., & Sibilia, J. (2006). Anti-pm/scl antibodies in connective tissue disease: clinical and biological assessment of 14 patients. Clinical and Experimental Rheumatology, 24(2), 129-133.
  10. 60. Willard-Gallo, K., Badran, B., Ravoet, M., Zerghe, A., Burny, A., Martiat, P., Goldman, M., Roufosse, F., & Sibille, C. (2005). Defective CD3gamma gene transcription is associated with NFATc2 overexpression in the lymphocytic variant of hypereosinophilic syndrome. Experimental hematology, 33(10), 1147-1159. doi:10.1016/j.exphem.2005.06.027
  11. 61. Ravoet, M., Sibille, C., Roufosse, F., Duvillier, H., Sotiriou, C., Schandené, L., Martiat, P., Goldman, M., & Willard-Gallo, K. (2005). 6q- is an early and persistent chromosomal aberration in CD3-CD4+ T-cell clones associated with the lymphocytic variant of hypereosinophilic syndrome. Haematologica, 90(6), 753-765.
  12. 62. Ysebrant De Lendonck, L., Ocmant, A., Roufosse, F., & Cogan, E. (2005). Predictive markers for development of severe organ involvement in patients with systemic sclerosis. New York Academy of Sciences. Annals, 1051, 1-10. doi:10.1196/annals.1361.087

  13. << Précédent 1 2 3 4 5 6 7 8 9 Suivant >>